Related Experiment Video
Updated: Apr 14, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Paradoxical topiramate-induced hyperphagia successfully treated with phentermine in a woman with migraine
Jacinta L Johnson1, Paul E Rolan2
1School of Medical Sciences, Faculty of Health Sciences, Medical School South Building, Frome Road, University of Adelaide, Adelaide, SA 5005, Australia.
Abstract:
We report a 49-year-old female migraineur who experienced paradoxical hyperphagia and concurrent intrusive food thoughts leading to rapid weight gain and a substantial increase in waist circumference. A significant reduction in migraine frequency was also observed during topiramate treatment, a widely used migraine prophylactic agent which is generally associated with weight loss. Withdrawal of topiramate saw appetite return to baseline levels, however, migraine frequency was again increased. Topiramate was reinitiated in combination with phentermine, a drug indicated for weight management, without reoccurrence of adverse effects. Migraine control was maintained and progressive weight loss ensued. Combination treatment with phentermine may be a useful strategy should other patients experience this adverse reaction while gaining therapeutic anti-migraine benefit from topiramate.
Related Concept Videos
Regulation of Food Intake
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antidepressant Drugs: MAOIs and Other Agents
Binge Eating Disorders
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Bulimia Nervosa

